Aehr Test Systems reported that during its current fiscal third quarter to date it has booked over $5.5 million in orders for its Sonoma AI processor diagnostic systems. These orders, placed by multiple leading-edge AI companies and a premier Bay Area lab, already exceed the total Sonoma system bookings recorded in the entire previous quarter. Management highlighted that demand from the artificial intelligence sector is a growing revenue driver as customers seek high-volume testing solutions for next-generation processor chips.

In its fiscal second quarter, Aehr Test Systems posted net revenue of $9.9 million, down 27% from $13.5 million in the year-ago period. Gross margin contracted to 36.2% due to lower consumables sales and continued R&D investments. The company recorded a GAAP net loss of $1.3 million, or $0.04 per share, reversing a profit of $700,000 in the prior-year quarter. Volume of system shipments remained subdued as customers delayed projects pending broader AI infrastructure rollouts.

After suspending its projections last summer, Aehr reinstated its financial guidance for the second half of fiscal 2026, forecasting revenue between $25 million and $30 million and a non-GAAP net loss of $0.05 to $0.09 per share. Management also disclosed expectations for second-half bookings of $60 million to $80 million, driven primarily by further AI diagnostic system deployments and expansion into memory chip test products. Investors will be watching to see if follow-through orders validate this outlook and drive a return to sustained profitability.